Novel Coronavirus (SARS-CoV-2/COVID-19)
The Department of Health and Human Services has renewed the COVID-19 public health emergency declaration for another 90 days effective Oct. 18.
The National Institutes of Health awarded a total of $78 million in funding to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, with the goal of bringing to market as soon as this year new home and point-of-care tests that can detect multiple respiratory infections.
Getting both viruses at once may lead to long-term damage or death.
CHOP鈥檚 online flu season resource center offers preventive measures, a look back at the history of the flu vaccine, 鈥淛ust the Vax鈥 trivia game and a fast facts on-the-go app .
The challenges presented by COVID-19 are by no means over as members contend with variants and vaccine hesitancy. Still, there are learnings that can inform and improve how members continue to cope with this ongoing public health crisis.
View Webinar
The AHA released the latest edition of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
A new study released by the National Academies of Sciences, Engineering and Medicine offers advice for communicating with parents about their children鈥檚 COVID-19 vaccination, along with strategies for building public confidence in the vaccines
Food and Drug Administration staff provided their analysis of Johnson & Johnson鈥檚 COVID-19 booster application, indicating that a second dose provides substantially more protection against SAR-CoV-2 than the initial shot.
The Centers for Disease Control and Prevention (CDC) has released an initial document intended to assist jurisdictions across the country in planning for the distribution and administration of COVID-19 vaccines to the pediatric population. The document provides initial information pertaining to鈥